Acute Liver Failure: Pathophysiologic Basis, and The Current and Emerging Therapies

Acute liver failure (ALF) is a devastating condition that occurs in patients who previously had a normal liver. Although the outcome of patients with ALF has improved, without liver transplantation (LT) mortality rates remain in the range of 35-50% in different geographical areas and therefore, its...

Full description

Bibliographic Details
Main Authors: Graziella Privitera, Banwari Agarwal, Rajiv Jalan
Format: Article
Language:English
Published: European Medical Journal 2014-05-01
Series:European Medical Journal Hepatology
Subjects:
Online Access:http://emjreviews.com/wp-content/uploads/Acute-Liver-Failure-Pathophysiologic-Basis-And-The-Current-And-Emerging-Therapies.pdf
id doaj-1503840a285c499a9f50d5842fee9e52
record_format Article
spelling doaj-1503840a285c499a9f50d5842fee9e522020-11-24T22:34:21ZengEuropean Medical JournalEuropean Medical Journal Hepatology2053-42212014-05-012199107Acute Liver Failure: Pathophysiologic Basis, and The Current and Emerging TherapiesGraziella Privitera0Banwari Agarwal1Rajiv Jalan2Department of Medicine, UCL Institute for Liver and Digestive Heath, University College London, Royal Free Hospital, London, United KingdomDepartment of Medicine, UCL Institute for Liver and Digestive Heath, University College London, Royal Free Hospital, London, United KingdomDepartment of Medicine, UCL Institute for Liver and Digestive Heath, University College London, Royal Free Hospital, London, United KingdomAcute liver failure (ALF) is a devastating condition that occurs in patients who previously had a normal liver. Although the outcome of patients with ALF has improved, without liver transplantation (LT) mortality rates remain in the range of 35-50% in different geographical areas and therefore, its treatment remains an unmet need. In the Western world toxic liver injury from acetaminophen remains one of the common causes but, in the East, hepatitis of unknown aetiology remains the most common cause. Treatment options are limited to meticulous attention to multi-organ support, use of N-acetyl cysteine, judicious use of antibiotics, and timely LT. This review describes the state-of-the-art techniques in the issues related to prognosis, outcome, and treatment of this devastating syndrome.http://emjreviews.com/wp-content/uploads/Acute-Liver-Failure-Pathophysiologic-Basis-And-The-Current-And-Emerging-Therapies.pdfacetaminophenintracranial hypertensionliver transplantationmulti-organ failureN-acetylcysteine
collection DOAJ
language English
format Article
sources DOAJ
author Graziella Privitera
Banwari Agarwal
Rajiv Jalan
spellingShingle Graziella Privitera
Banwari Agarwal
Rajiv Jalan
Acute Liver Failure: Pathophysiologic Basis, and The Current and Emerging Therapies
European Medical Journal Hepatology
acetaminophen
intracranial hypertension
liver transplantation
multi-organ failure
N-acetylcysteine
author_facet Graziella Privitera
Banwari Agarwal
Rajiv Jalan
author_sort Graziella Privitera
title Acute Liver Failure: Pathophysiologic Basis, and The Current and Emerging Therapies
title_short Acute Liver Failure: Pathophysiologic Basis, and The Current and Emerging Therapies
title_full Acute Liver Failure: Pathophysiologic Basis, and The Current and Emerging Therapies
title_fullStr Acute Liver Failure: Pathophysiologic Basis, and The Current and Emerging Therapies
title_full_unstemmed Acute Liver Failure: Pathophysiologic Basis, and The Current and Emerging Therapies
title_sort acute liver failure: pathophysiologic basis, and the current and emerging therapies
publisher European Medical Journal
series European Medical Journal Hepatology
issn 2053-4221
publishDate 2014-05-01
description Acute liver failure (ALF) is a devastating condition that occurs in patients who previously had a normal liver. Although the outcome of patients with ALF has improved, without liver transplantation (LT) mortality rates remain in the range of 35-50% in different geographical areas and therefore, its treatment remains an unmet need. In the Western world toxic liver injury from acetaminophen remains one of the common causes but, in the East, hepatitis of unknown aetiology remains the most common cause. Treatment options are limited to meticulous attention to multi-organ support, use of N-acetyl cysteine, judicious use of antibiotics, and timely LT. This review describes the state-of-the-art techniques in the issues related to prognosis, outcome, and treatment of this devastating syndrome.
topic acetaminophen
intracranial hypertension
liver transplantation
multi-organ failure
N-acetylcysteine
url http://emjreviews.com/wp-content/uploads/Acute-Liver-Failure-Pathophysiologic-Basis-And-The-Current-And-Emerging-Therapies.pdf
work_keys_str_mv AT graziellaprivitera acuteliverfailurepathophysiologicbasisandthecurrentandemergingtherapies
AT banwariagarwal acuteliverfailurepathophysiologicbasisandthecurrentandemergingtherapies
AT rajivjalan acuteliverfailurepathophysiologicbasisandthecurrentandemergingtherapies
_version_ 1725728056398577664